Breaking News

Bioniche Names COO

By Kristin Brooks | January 8, 2014

Olds brings scientific, operational, and financial experience

Donald Olds has been appointed chief operating officer at Bioniche Life Sciences. Prior to joining the company, Mr. Olds held key executive positions in biotechnology, investment banking, biotechnology and IT, and has led successful licensing, merger and acquisition and debt and equity transactions. He currently serves as chairman of the board of the Neomed Institute, director and chair of the Audit Committee of the Centre Quebecois, director of Bellus Health, and is treasurer of Oxfam Quebec.
 
Dr. Michael Berendt, chief executive officer of Bioniche Life Sciences Inc., said, "The engagement of Donald Olds is the next step in our operational plan to position Bioniche Life Sciences as a top-tier North American biotechnology company with a focus on the development of oncology therapeutics. Don brings a rare combination of scientific, operational, and financial acumen that we are confident will help us position our human therapeutic business for future success and permit us to achieve our other operational objectives, including the licensing and divestiture of our non-core business assets and the implementation of operating cost reductions."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks